Analysis of a gene variant of the chemokine receptor CCR5 in patients with systemic lupus erythematosus

被引:0
|
作者
Schauren, J. S. [1 ]
Veit, T. D. [1 ]
Monticielo, O. A. [2 ]
Mucenic, T. [2 ]
Brenol, J. C. [2 ]
Marasca, J. A. [2 ]
Xavier, R. M. [2 ]
Chies, J. A. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
来源
TISSUE ANTIGENS | 2011年 / 77卷 / 05期
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:494 / 494
页数:1
相关论文
共 50 条
  • [41] The expression of the chemokine receptor CCR5 in psoriasis and the results of a randomized placebo controlled trial with a CCR5 receptor inhibitor
    de Groot, M.
    Picavet, D. I.
    de Rie, M. A.
    Teunissen, M. B.
    Bos, J. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S39 - S39
  • [42] The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients
    Kohem, Cl
    Brenol, Jct
    Xavier, Rm
    Bredemeier, M.
    Brenol, Cv
    Silva, Tl Dedavid E.
    Mello, A. De Castilhos
    Canedo, Ad
    Neves, Ag
    Chies, Jab
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2007, 36 (05) : 359 - 364
  • [43] Peripheral Monocyte Expression of the Chemokine Receptors CCR2, CCR5 and CXCR3 is Altered at Parturition in Healthy Women and in Women with Systemic Lupus Erythematosus
    Bjorkander, S.
    Heidari-Hamedani, G.
    Bremme, K.
    Gunnarsson, I.
    Holmlund, U.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 77 (03) : 200 - 212
  • [44] CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients
    Thiago Hissnauer Leal Baltus
    Ana Paula Kallaur
    Marcell Alysson Batisti Lozovoy
    Helena Kaminami Morimoto
    Francieli Delongui
    Daniela Frizon Alfieri
    Tatiane Mayumi Veiga Iriyoda
    Isaias Dichi
    Andrea Name Colado Simão
    Edna Maria Vissoci Reiche
    Rheumatology International, 2016, 36 : 7 - 15
  • [45] CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients
    Leal Baltus, Thiago Hissnauer
    Kallaur, Ana Paula
    Batisti Lozovoy, Marcell Alysson
    Morimoto, Helena Kaminami
    Delongui, Francieli
    Alfieri, Daniela Frizon
    Veiga Iriyoda, Tatiane Mayumi
    Dichi, Isaias
    Colado Simao, Andrea Name
    Vissoci Reiche, Edna Maria
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (01) : 7 - 15
  • [46] Clinical studies with chemokine receptor-5 (CCR5)-inhibitors
    Boesecke, Christoph
    Pett, Sarah L.
    CURRENT OPINION IN HIV AND AIDS, 2012, 7 (05) : 456 - 462
  • [47] Chemokine receptor CCR5: insights into structure, function, and regulation
    Oppermann, M
    CELLULAR SIGNALLING, 2004, 16 (11) : 1201 - 1210
  • [48] A hammerhead ribozyme targeted to the human chemokine receptor CCR5
    González, MA
    Serrano, F
    Llorente, M
    Abad, JL
    García-Ortiz, MJ
    Bernad, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 251 (02) : 592 - 596
  • [49] Association of rheumatoid arthritis with a functional chemokine receptor, CCR5
    Gómez-Reino, JJ
    Pablos, JL
    Carreira, PE
    Santiago, B
    Serrano, L
    Vicario, JL
    Balsa, A
    Figueroa, M
    De Juan, MD
    ARTHRITIS AND RHEUMATISM, 1999, 42 (05): : 989 - 992
  • [50] Soluble chemokine CCR5 receptor is present in human plasma
    Tsimanis, A
    Kalinkovich, A
    Bentwich, Z
    IMMUNOLOGY LETTERS, 2005, 96 (01) : 55 - 61